194 related articles for article (PubMed ID: 30187220)
41. Single-institutional outcomes of adjuvant brachytherapy for Stage I endometrial cancer-Are outcomes consistent with randomized studies?
Dohopolski MJ; Horne ZD; Gebhardt BJ; Glaser SM; Edwards RP; Kelley JL; Comerci JT; Olawaiye AB; Courtney-Brooks M; Berger JL; Sukumvanich P; Beriwal S
Brachytherapy; 2018; 17(3):564-570. PubMed ID: 29426745
[TBL] [Abstract][Full Text] [Related]
42. The role of vaginal brachytherapy in the treatment of surgical stage I papillary serous or clear cell endometrial cancer.
Barney BM; Petersen IA; Mariani A; Dowdy SC; Bakkum-Gamez JN; Haddock MG
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):109-15. PubMed ID: 22543202
[TBL] [Abstract][Full Text] [Related]
43. Chore or priority? Barriers and facilitators affecting dilator use after pelvic radiotherapy for gynaecological cancer.
Bonner C; Nattress K; Anderson C; Carter J; Milross C; Philp S; Juraskova I
Support Care Cancer; 2012 Oct; 20(10):2305-13. PubMed ID: 22160621
[TBL] [Abstract][Full Text] [Related]
44. High dose rate vaginal brachytherapy in early stage endometrial carcinoma: preliminary analysis.
Hong JJ; Yacoub SF; Blevins JC; Kuban DA; el-Mahdi AM
Am J Clin Oncol; 1997 Jun; 20(3):254-8. PubMed ID: 9167748
[TBL] [Abstract][Full Text] [Related]
45. Multi-institutional Analysis of Vaginal Brachytherapy Alone for Women With Stage II Endometrial Carcinoma.
Harkenrider MM; Martin B; Nieto K; Small C; Aref I; Bergman D; Chundury A; Elshaikh MA; Gaffney D; Jhingran A; Lee L; Paydar I; Ra K; Schwarz J; Thorpe C; Viswanathan AN; Small W
Int J Radiat Oncol Biol Phys; 2018 Aug; 101(5):1069-1077. PubMed ID: 29885996
[TBL] [Abstract][Full Text] [Related]
46. Clinical and Psychological Outcomes of the Use of Vaginal Dilators After Gynaecological Brachytherapy: a Randomized Clinical Trial.
Cerentini TM; Schlöttgen J; Viana da Rosa P; La Rosa VL; Vitale SG; Giampaolino P; Valenti G; Cianci S; Macagnan FE
Adv Ther; 2019 Aug; 36(8):1936-1949. PubMed ID: 31209699
[TBL] [Abstract][Full Text] [Related]
47. Intravaginal 1-week high-dose-rate brachytherapy alone for Stages I-II endometrial cancer.
Martínez-Monge R; Nagore G; Cambeiro M; Garrán C; Villafranca E; Jurado M
Brachytherapy; 2007; 6(3):195-200. PubMed ID: 17681240
[TBL] [Abstract][Full Text] [Related]
48. Definitive salvage for vaginal recurrence of endometrial cancer: the impact of modern intensity-modulated-radiotherapy with image-based HDR brachytherapy and the interplay of the PORTEC 1 risk stratification.
Vargo JA; Kim H; Houser CJ; Berhane H; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Huang M; Courtney-Brooks M; Beriwal S
Radiother Oncol; 2014 Oct; 113(1):126-31. PubMed ID: 25241996
[TBL] [Abstract][Full Text] [Related]
49. Isolated vaginal recurrences in endometrial carcinoma: treatment results using high-dose-rate intracavitary brachytherapy and external beam radiotherapy.
Pai HH; Souhami L; Clark BG; Roman T
Gynecol Oncol; 1997 Aug; 66(2):300-7. PubMed ID: 9264580
[TBL] [Abstract][Full Text] [Related]
50. Salvage high-dose-rate brachytherapy and external beam radiotherapy for isolated vaginal recurrences of endometrial cancer with no prior adjuvant therapy.
Chapman CH; Maghsoudi K; Littell RD; Chen LM; Hsu IC
Brachytherapy; 2017; 16(6):1152-1158. PubMed ID: 28802913
[TBL] [Abstract][Full Text] [Related]
51. Late reactions after postoperative high-dose-rate intravaginal brachytherapy for endometrial cancer: a comparison of standardized and individualized target volumes.
Onsrud M; Strickert T; Marthinsen AB
Int J Radiat Oncol Biol Phys; 2001 Mar; 49(3):749-55. PubMed ID: 11172958
[TBL] [Abstract][Full Text] [Related]
52. External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma--a prospective randomized study.
Sorbe B; Horvath G; Andersson H; Boman K; Lundgren C; Pettersson B
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1249-55. PubMed ID: 21676554
[TBL] [Abstract][Full Text] [Related]
53. Change in vaginal length and sexual function in women who undergo surgery ± radiation therapy for endometrial cancer.
Quinn BA; Deng X; Sullivan SA; Carter J; Bandyopadhyay D; Fields EC
Brachytherapy; 2023; 22(3):334-342. PubMed ID: 36849277
[TBL] [Abstract][Full Text] [Related]
54. Does adjuvant concurrent or sequential chemotherapy increase the radiation-related toxicity of vaginal brachytherapy for endometrial cancer patients?
Nieto K; Martin B; Pham N; Palmere L; Silva SR; Winder A; Liotta M; Potkul RK; Small W; Harkenrider MM
Brachytherapy; 2018; 17(6):929-934. PubMed ID: 30227976
[TBL] [Abstract][Full Text] [Related]
55. Local recurrence in high-risk node-negative stage I endometrial carcinoma treated with postoperative vaginal vault brachytherapy.
Ng TY; Perrin LC; Nicklin JL; Cheuk R; Crandon AJ
Gynecol Oncol; 2000 Dec; 79(3):490-4. PubMed ID: 11104626
[TBL] [Abstract][Full Text] [Related]
56. Radiation therapy improves disease-specific survival in women with Stage II endometrioid endometrial cancer-Brachytherapy may be sufficient.
Nwachukwu CR; Von-Eyben R; Kidd EA
Brachytherapy; 2018; 17(2):383-391. PubMed ID: 29198879
[TBL] [Abstract][Full Text] [Related]
57. Diagnostic Methods for Vaginal Stenosis and Compliance to Vaginal Dilator Use: A Systematic Review.
Haddad NC; Soares Brollo LC; Pinho Oliveira MA; Bernardo-Filho M
J Sex Med; 2021 Mar; 18(3):493-514. PubMed ID: 33526400
[TBL] [Abstract][Full Text] [Related]
58. Postoperative vaginal brachytherapy alone is the treatment of choice for grade 1-2, stage IC endometrial cancer.
Cengiz M; Singh AK; Grigsby PW
Int J Gynecol Cancer; 2005; 15(5):926-31. PubMed ID: 16174247
[TBL] [Abstract][Full Text] [Related]
59. A nurse-led sexual rehabilitation intervention after radiotherapy for gynecological cancer.
Bakker RM; Mens JW; de Groot HE; Tuijnman-Raasveld CC; Braat C; Hompus WC; Poelman JG; Laman MS; Velema LA; de Kroon CD; van Doorn HC; Creutzberg CL; Ter Kuile MM
Support Care Cancer; 2017 Mar; 25(3):729-737. PubMed ID: 27787681
[TBL] [Abstract][Full Text] [Related]
60. Primary radiotherapy for nonsurgically managed Stage I endometrial cancer: Utilization and impact of brachytherapy.
Gill BS; Chapman BV; Hansen KJ; Sukumvanich P; Beriwal S
Brachytherapy; 2015; 14(3):373-9. PubMed ID: 25600451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
